)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
LeonaBio
LeonaBio (LONA) investor relations material
LeonaBio Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary31 Mar, 2026
Company overview and business model
Clinical-stage biopharmaceutical company focused on novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and ALS.
Lead drug candidates are lasofoxifene and ATH-1105, both small molecule therapies targeting diseases with limited current treatment options.
Pipeline includes additional candidates such as ATH-1020 and early-stage compounds for neurodegenerative diseases.
Incorporated in Washington in 2011, converted to Delaware in 2015, and renamed in January 2026.
Financial performance and metrics
As of March 16, 2026, 9,393,514 shares of common stock were outstanding with 38 holders of record.
No outstanding preferred stock as of March 16, 2026.
Use of proceeds and capital allocation
Will not receive proceeds from the sale of shares by the selling stockholder.
Will receive up to $5,502 from the cash exercise of the pre-funded warrant, intended for working capital and advancement of lasofoxifene and pipeline drug candidates.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from LeonaBio
- 58.5M shares registered for resale; warrant exercises could yield over $146M for clinical programs.LONA
Registration filing31 Mar 2026 - Secured lasofoxifene license, raised $90M, and advanced clinical pipeline amid higher R&D spend.LONAQ4 202526 Mar 2026
- All proposals, including key share issuances and governance changes, were approved by majority vote.LONAEGM 202618 Mar 2026
- Proposal 6 is now routine, enabling discretionary broker voting at the March 2026 meeting.LONAProxy Filing10 Mar 2026
- Shareholders to vote on major share issuances, new equity plan, and increased authorized stock.LONAProxy Filing23 Feb 2026
- Shareholders to vote on key share issuances, new equity plan, and major charter amendment.LONAProxy Filing4 Feb 2026
- Exclusive lasofoxifene license and $236M financing drive late-stage cancer and ALS programs.LONAStatus Update3 Feb 2026
- Fosgonimeton is tested in a pivotal Alzheimer's trial using GST, with results due in 2H24.LONAStatus Update3 Feb 2026
- Pivotal Alzheimer's trial readout expected in fall, with strong cash position and ALS expansion planned.LONAGoldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026
Next LeonaBio earnings date
Q1 20268 May, 2026
LeonaBio
Next LeonaBio earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage